Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 585-596

  Aldinucci, Donatella ^a   Poletto, Dalisa ^a   Gloghini, Annunziata ^a   Nanni, Paola ^a   Degan, Massimo ^a   Perin, Tiziana ^a   Ceolin, Paola ^a   Rossi, Francesca Maria ^a   Gattei, Valter ^a   Carbone, Antonino ^a   Pinto, Antonio ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 5;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL MATURATION; CELL POPULATION; CELL STIMULATION; CELL SUSPENSION; CYTOKINE RELEASE; FLOW CYTOMETRY; FROZEN SECTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

EID: 0036169090     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64878-X     Document Type: Article

References (67)

1. The histopathologic diagnosis and subclassification of Hodgkin's disease
2. Hodgkin's disease: Classification and differential diagnosis
3. Pathophysiology of Hodgkin's disease: Functional and molecular aspects
4. Hodgkin's disease: A tumor with disturbed immunological pathways
5. Hodgkin's disease: A disorder of dysregulated cellular cross-talk
6. Reed-Sternberg cell: Survival in a hostile sea
7. Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia
8. Hodgkin/Reed-Sternberg cells induce fibroblast to secrete eotaxin, a potent chemoattractant for T-cells and eosinophils
9. Interleukin-4 is an autocrine growth factor secreted by the L-428 Reed-Sternberg cell
10. Expression of interleukin-6 and interleukin 6 receptor in Hodgkin's disease
11. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma
12. Interleukin-9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells
13. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants
14. Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation
15. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells
16. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas
17. Expression of functional CD40 antigen on ReedSternberg cells and Hodgkin's disease cell lines
18. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines
19. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors
20. The structural and functional basis of cytokine receptor activation: Lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) and IL-5
21. Mechanism of activation of the GM-CSF-IL-3, and IL-5 family of receptors
22. Interleukin-3
23. Signal transduction, cell cycle regulatory, and Anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: Possible sites for intervention with anti-neoplastic drugs
24. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
25. Recent results on the biology of Hodgkin and Reed Sternberg cells. II. Continuous cell lines
26. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give raise to permanently growing Hodgkin-Reed Sternberg cells
27. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas
28. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
29. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin
30. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells
31. Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor α-chain and function as a specific IL-3 receptor antagonist
32. Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor α- and β-chain heterodimerization, which is required for receptor activation but not high-affinity binding
33. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95
34. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease
35. Cellular origin and clonality of classic Hodgkin's lymphoma: Immunophenotypic and molecular studies
36. Reed-Sternberg cell genome expression supports a B-cell lineage
37. Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells
38. Characterization of human leucocytes bearing the IL-3 receptor
39. Proliferative effect of interleukin-3 on normal and leukemic human B-cell precursors
40. Interleukin-3, GMCSF and G-CSF receptor expression on cell lines and primary leukemia cells: Receptor heterogeneity and relationship to growth factor responsiveness
41. Leukemic B-cell precursors express functional receptors for human interleukin-3
42. Survival of human leukemic B-cell precursors is supported by stromal cells and cytokines: Association with the expression of bcl-2 protein
43. Interleukin 3 is a growth factor for human follicular B cell lymphoma
44. Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3
45. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia
46. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma
47. The antigen-presenting-cell function of Reed-Sternberg cells
48. Immune reactions in classical Hodgkin's lymphoma
49. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?
50. Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma
51. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma
52. Immunobiology of dendritic cells
53. The enigmatic plasmacytoid T-cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
54. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines
55. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L 1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient
56. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes
57. Two distinct interleukin-3-mediated signal pathways, RAS-NFIL3 (E4BP4) and Bcl-xl, regulate the survival of murine pro-B lymphocytes
58. Human recombinant IL-3 is a growth factor for normal B cells
59. Human recombinant IL-3 stimulates B-cell differentiation
60. Cytokine expression in T-cell lymphomas and Hodgkin's disease
61. Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations
62. Granulocyte/macrophage colony-stimulating factor and interleukin-3 release from human peripheral blood eosinophils and neutrophils
63. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
64. The expanding universe of T-cell subsets: Th1, Th2 and more
65. Cytokine profiles
66. Contribution of interleukin-3 to antigen-induced Th2 cytokine production
67. IL-3 augments TCR-mediated responses of type 2 CD4 T cells